The most recurrent genetic alterations in non-small cell lung cancer (NSCLC, 85% of lung cancers) consist of mutations in the epidermal growth factor receptor (EGFR) gene, leading to uncontrolled cellular proliferation, inhibition of apoptosis and thus, tissue growth and cancer. The gene discussed is EGFR; the disease is lung carcinoma.